Frontline chemotherapy-free induction for mantle cell lymphoma

Lancet Oncol. 2022 Mar;23(3):321-322. doi: 10.1016/S1470-2045(21)00721-X. Epub 2022 Jan 21.

Authors

Umberto Vitolo¹, Mattia Novo²

Affiliations

¹ Multidisciplinary Outpatient Oncology Clinic, Candiolo Cancer Institute, FPO-IRCCS, Candiolo (Turin) 10060, Italy. Electronic address: umberto.vitolo@ircc.it.
² Multidisciplinary Outpatient Oncology Clinic, Candiolo Cancer Institute, FPO-IRCCS, Candiolo (Turin) 10060, Italy.

PMID: 35074073
DOI: 10.1016/S1470-2045(21)00721-X

No abstract available

Publication types

Comment

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Humans
Lymphoma, Mantle-Cell* / drug therapy
Lymphoma, Mantle-Cell* / pathology
Rituximab / therapeutic use

Substances

Rituximab